Article Details
Retrieved on: 2021-03-02 15:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... freeing up the company to focus on its core businesses in gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience.
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here